STERIS Announces Financial Results for Fiscal 2022 First Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
STERIS (STE) PT Raised to $254 at Needham & Company
August 10, 2021 12:05 PM EDTNeedham & Company analyst Mike Matson raised the price target on STERIS (NYSE: STE) to $254.00 (from $233.00) while maintaining a Buy rating.
The analyst commented, "STE's F1Q22 revenue and EPS beat consensus. Organic revenue growth improved significantly from the prior quarter as STE lapped the... More
